My Ex-Wife and Kids Came In Like A Wrecking Ball

Chapter 1542 Nothing To Talk About "Rosie's part of this research is the technology. The medicinal materials given by Lancer Corporation were just for this batch. If you aren't happy with the division of profit, it doesn't matter. We can divide the profit for this batch of drugs produced using your materials by the percentage you're satisfied with. However, the research institute also has the right to only sign the contract of this batch of drugs with you.”

Then, Byron continued slowly, 'This means that after this batch of drugs is sold, Rosie can take the technology to seek cooperation with other suppliers of medicinal materials. What about Lancer Corporation? Where else can you find an institute that can make it?"

He was implying the status of the research institute was higher than Lancer Corporation in this project.

Rosalie did not need Lancer Corporation.

Instead, Lancer Corporation needed Rosalie to get the drug produced.

The party leading the project should be the research institute instead of Lancer Corporation from the beginning.

As for Xander, he could choose short-term interests or long-term benefits through this matter.

this. He glanced at Byron coldly but still chose to speak to

business-like method, Miss Jacobs? Is Lancer Corporation so worthless that you can

at Byron. She felt secure with Byron's confident nod. Thus, she chose to remain silent as an

you understand this more than Rosie does, don’t you? The division of profit is

using the strategy of making use of your friendship with Rosie to get her

not as good as Byron at negotiating, and Byron's words made

silence, he spoke word by word,

Corporation's profits were distributed with partners when we occupied technology

those figures, you might be satisfied with the share

Xander if he were to set the distribution,

plastered friendliness shattered, and he glared at them

terms. If you aren't satisfied, our research institute is also willing to invite professionals to evaluate the early investment of Lancer Corporation